Alan N Francis1, Suraj S Mothi2, Ian T Mathew2, Neeraj Tandon2, Brett Clementz3, Godfrey D Pearlson4, John A Sweeney5, Carol A Tamminga5, Matcheri S Keshavan2. 1. Brain Imaging Center, McLean Hospital, Harvard Medical School, Belmont, Massachusetts. Electronic address: afrancis@mclean.harvard.edu. 2. Beth Israel Deaconess Medical Center, Harvard University, Boston. 3. Department of Psychology and Neuroscience, Bio-Imaging Research Center, University of Georgia, Athens, Georgia. 4. Olin Neuropsychiatry Research Center, Institute of Living, Hartford; Yale University School of Medicine, New Haven, Connecticut. 5. University of Texas Southwestern Medical Center, Dallas, Texas.
Abstract
BACKGROUND: The corpus callosum has been implicated in the pathogenesis of schizophrenia and bipolar disorder. However, it is unclear whether corpus callosum alterations are related to the underlying familial diathesis for psychotic disorders. We examined the corpus callosum and its subregion volumes and their relationship to cognition, psychotic symptoms, and age in probands with schizophrenia (SZ), psychotic bipolar disorder (PBD), and schizoaffective disorder; their first-degree relatives; and healthy control subjects. METHODS: We present findings from morphometric and neurocognitive analyses of 1381 subjects (SZ probands, n = 224; PBD probands, n = 190; schizoaffective disorder probands, n = 142; unaffected relatives, n = 483 [SZ relatives, n = 195; PBD relatives, n = 175; schizoaffective disorder relatives, n = 113]; control subjects, n = 342). Magnetization prepared rapid acquisition gradient-echo T1 scans across five sites were obtained using 3-tesla magnets. Image processing was done using FreeSurfer Version 5.1. Neurocognitive function was measured using the Brief Assessment of Cognition in Schizophrenia scale. RESULTS: Anterior and posterior splenial volumes were significantly reduced across the groups. The SZ and PBD probands showed robust and significant reductions, whereas relatives showed significant reductions of intermediate severity. The splenial volumes were positively but differentially correlated with aspects of cognition in the probands and their relatives. Proband groups showed a significant age-related decrease in the volume of the anterior splenium compared with control subjects. Among the psychosis groups, the anterior splenium in probands with PBD showed a stronger correlation with psychotic symptoms, as shown by the Positive and Negative Syndrome Scale. All five subregions showed significantly high familiality. CONCLUSIONS: The splenial volumes were significantly reduced across the psychosis dimension. However, this volume reduction impacts cognition and clinical manifestation of the illnesses differentially.
BACKGROUND: The corpus callosum has been implicated in the pathogenesis of schizophrenia and bipolar disorder. However, it is unclear whether corpus callosum alterations are related to the underlying familial diathesis for psychotic disorders. We examined the corpus callosum and its subregion volumes and their relationship to cognition, psychotic symptoms, and age in probands with schizophrenia (SZ), psychotic bipolar disorder (PBD), and schizoaffective disorder; their first-degree relatives; and healthy control subjects. METHODS: We present findings from morphometric and neurocognitive analyses of 1381 subjects (SZ probands, n = 224; PBD probands, n = 190; schizoaffective disorder probands, n = 142; unaffected relatives, n = 483 [SZ relatives, n = 195; PBD relatives, n = 175; schizoaffective disorder relatives, n = 113]; control subjects, n = 342). Magnetization prepared rapid acquisition gradient-echo T1 scans across five sites were obtained using 3-tesla magnets. Image processing was done using FreeSurfer Version 5.1. Neurocognitive function was measured using the Brief Assessment of Cognition in Schizophrenia scale. RESULTS: Anterior and posterior splenial volumes were significantly reduced across the groups. The SZ and PBD probands showed robust and significant reductions, whereas relatives showed significant reductions of intermediate severity. The splenial volumes were positively but differentially correlated with aspects of cognition in the probands and their relatives. Proband groups showed a significant age-related decrease in the volume of the anterior splenium compared with control subjects. Among the psychosis groups, the anterior splenium in probands with PBD showed a stronger correlation with psychotic symptoms, as shown by the Positive and Negative Syndrome Scale. All five subregions showed significantly high familiality. CONCLUSIONS: The splenial volumes were significantly reduced across the psychosis dimension. However, this volume reduction impacts cognition and clinical manifestation of the illnesses differentially.
Authors: T J Crow; J Ball; S R Bloom; R Brown; C J Bruton; N Colter; C D Frith; E C Johnstone; D G Owens; G W Roberts Journal: Arch Gen Psychiatry Date: 1989-12
Authors: M S Keshavan; V A Diwadkar; K Harenski; D R Rosenberg; J A Sweeney; J W Pettegrew Journal: J Neurol Neurosurg Psychiatry Date: 2002-06 Impact factor: 10.154
Authors: Sara J M Arnold; Elena I Ivleva; Tejas A Gopal; Anil P Reddy; Haekyung Jeon-Slaughter; Carolyn B Sacco; Alan N Francis; Neeraj Tandon; Anup S Bidesi; Bradley Witte; Gaurav Poudyal; Godfrey D Pearlson; John A Sweeney; Brett A Clementz; Matcheri S Keshavan; Carol A Tamminga Journal: Schizophr Bull Date: 2014-02-20 Impact factor: 9.306
Authors: Sarah L M Johnson; Deanna Greenstein; Liv Clasen; Rachel Miller; Francois Lalonde; Judith Rapoport; Nitin Gogtay Journal: Psychiatry Res Date: 2012-11-13 Impact factor: 3.222
Authors: Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson Journal: World Psychiatry Date: 2020-06 Impact factor: 49.548
Authors: Dirk Jan Ardesch; Lianne H Scholtens; Siemon C de Lange; Lea Roumazeilles; Alexandre A Khrapitchev; Todd M Preuss; James K Rilling; Rogier B Mars; Martijn P van den Heuvel Journal: Cereb Cortex Date: 2022-06-16 Impact factor: 4.861
Authors: Rachael G Grazioplene; Carrie E Bearden; Kenneth L Subotnik; Joseph Ventura; Kristen Haut; Keith H Nuechterlein; Tyrone D Cannon Journal: Neuroimage Clin Date: 2018-02-22 Impact factor: 4.881
Authors: Timothy Hughes; Ida E Sønderby; Tatiana Polushina; Lars Hansson; Asbjørn Holmgren; Lavinia Athanasiu; Christian Melbø-Jørgensen; Sahar Hassani; Louise K Hoeffding; Stefan Herms; Sarah E Bergen; Robert Karlsson; Jie Song; Marcella Rietschel; Markus M Nöthen; Andreas J Forstner; Per Hoffmann; Christina M Hultman; Mikael Landén; Sven Cichon; Thomas Werge; Ole A Andreassen; Stephanie Le Hellard; Srdjan Djurovic Journal: Transl Psychiatry Date: 2018-10-08 Impact factor: 6.222